Ligand validation:5R28

RDJ: N-ethyl-2-{[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide

RDJ is a Ligand Of Interest in 5R28 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5R28_RDJ_A_401	2%	44%	0.455	0.728	0.46	1.7	-	1	0	0	100%	0.28
5RCA_RDJ_A_401	30%	28%	0.191	0.854	1.19	1.85	2	1	0	0	100%	0.22
8OHJ_RDJ_B_301	23%	7%	0.255	0.88	1.95	3.09	2	2	0	0	100%	2.1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.